$LCII
LCI INDUSTRIES

2024 Q3 Form 10-Q Financial Statement

#000076374424000109 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $915.5M $1.055B
YoY Change -4.57% 3.93%
Cost Of Revenue $695.5M $788.1M
YoY Change -7.06% -1.06%
Gross Profit $220.0M $266.4M
YoY Change 4.27% 22.16%
Gross Profit Margin 24.03% 25.27%
Selling, General & Admin $166.1M $175.8M
YoY Change 0.43% 7.91%
% of Gross Profit 75.5% 66.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $31.27M $32.04M
YoY Change -6.0% -3.06%
% of Gross Profit 14.22% 12.02%
Operating Expenses $166.1M $175.8M
YoY Change 0.43% 7.91%
Operating Profit $53.89M $90.60M
YoY Change 18.2% 64.22%
Interest Expense -$6.516M -$7.962M
YoY Change -36.89% -22.31%
% of Operating Profit -12.09% -8.79%
Other Income/Expense, Net
YoY Change
Pretax Income $47.37M $82.64M
YoY Change 34.33% 83.96%
Income Tax $11.76M $21.48M
% Of Pretax Income 24.82% 25.99%
Net Earnings $35.61M $61.16M
YoY Change 37.57% 82.98%
Net Earnings / Revenue 3.89% 5.8%
Basic Earnings Per Share $1.40 $2.40
Diluted Earnings Per Share $1.39 $2.40
COMMON SHARES
Basic Shares Outstanding 25.46M shares 25.45M shares
Diluted Shares Outstanding 25.56M shares 25.50M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.2M $130.4M
YoY Change 415.92% 490.29%
Cash & Equivalents $161.2M $130.4M
Short-Term Investments
Other Short-Term Assets $59.08M $67.64M
YoY Change -13.95% -19.15%
Inventory $705.4M $687.9M
Prepaid Expenses
Receivables $319.2M $333.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.245B $1.219B
YoY Change 1.16% -1.32%
LONG-TERM ASSETS
Property, Plant & Equipment $443.3M $448.0M
YoY Change -6.17% -6.44%
Goodwill $593.9M $588.5M
YoY Change 2.41% 0.72%
Intangibles $412.8M $421.7M
YoY Change -10.73% -11.65%
Long-Term Investments
YoY Change
Other Assets $96.82M $94.92M
YoY Change 77.37% 59.53%
Total Long-Term Assets $1.780B $1.793B
YoY Change -1.28% -2.62%
TOTAL ASSETS
Total Short-Term Assets $1.245B $1.219B
Total Long-Term Assets $1.780B $1.793B
Total Assets $3.025B $3.012B
YoY Change -0.29% -2.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $193.6M $202.6M
YoY Change -2.65% 10.94%
Accrued Expenses $199.1M $190.7M
YoY Change 10.67% -2.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $222.0K $558.0K
YoY Change -60.78% -97.99%
Total Short-Term Liabilities $432.0M $432.5M
YoY Change 4.34% -2.03%
LONG-TERM LIABILITIES
Long-Term Debt $822.3M $829.2M
YoY Change -9.46% -9.45%
Other Long-Term Liabilities $115.8M $112.1M
YoY Change 12.59% 8.4%
Total Long-Term Liabilities $938.1M $941.3M
YoY Change -7.22% -7.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $432.0M $432.5M
Total Long-Term Liabilities $938.1M $941.3M
Total Liabilities $1.607B $1.618B
YoY Change -3.31% -5.16%
SHAREHOLDERS EQUITY
Retained Earnings $1.228B $1.220B
YoY Change 1.82% 1.03%
Common Stock $252.5M $247.3M
YoY Change 4.66% 4.87%
Preferred Stock
YoY Change
Treasury Stock (at cost) $82.22M $82.22M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $1.418B $1.394B
YoY Change
Total Liabilities & Shareholders Equity $3.025B $3.012B
YoY Change -0.29% -2.09%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $35.61M $61.16M
YoY Change 37.57% 82.98%
Depreciation, Depletion And Amortization $31.27M $32.04M
YoY Change -6.0% -3.06%
Cash From Operating Activities $78.41M $192.9M
YoY Change -32.23% -2.99%
INVESTING ACTIVITIES
Capital Expenditures $10.06M $12.72M
YoY Change -37.03% -24.84%
Acquisitions
YoY Change
Other Investing Activities $229.0K -$19.58M
YoY Change -481.67% 13.71%
Cash From Investing Activities -$9.833M -$32.30M
YoY Change -38.69% -5.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.10M -52.65M
YoY Change -57.73% -68.38%
NET CHANGE
Cash From Operating Activities 78.41M 192.9M
Cash From Investing Activities -9.833M -32.30M
Cash From Financing Activities -38.10M -52.65M
Net Change In Cash 30.48M 108.0M
YoY Change 219.74% -6285.11%
FREE CASH FLOW
Cash From Operating Activities $78.41M $192.9M
Capital Expenditures $10.06M $12.72M
Free Cash Flow $68.34M $180.2M
YoY Change -31.46% -0.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25273000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
86000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25367000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25359000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
290000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162000 shares
CY2024Q2 us-gaap Dividends Cash
DividendsCash
26734000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1394413000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-697000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4385000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
863000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q2 us-gaap Dividends Cash
DividendsCash
26591000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1370897000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1355036000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
36545000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
122023 shares
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-9040000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4327000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3263000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2024Q1 us-gaap Dividends Cash
DividendsCash
26721000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1356884000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
61163000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14059 shares
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-71000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4974000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1803000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to product returns, sales and purchase rebates, accounts receivable, inventories, goodwill and other intangible assets, net assets of acquired businesses, income taxes, warranty and product recall obligations, self-insurance obligations, operating lease right-of-use assets and obligations, asset retirement obligations, long-lived assets, pension and post-retirement benefits, stock-based compensation, segment allocations, contingent consideration, environmental liabilities, contingencies, and litigation. The Company bases its estimates on historical experience, other available information, and various other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other resources. Actual results and events could differ significantly from management estimates.</span></div>
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25473000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25329000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25344000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
31000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
108000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25504000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25437000 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
289000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2800000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
100100000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
589550000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1709000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2736000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
588523000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
742920000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
321207000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
421713000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
742048000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
293289000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
448759000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
411029000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
457877000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
42213000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
45112000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
234628000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
265418000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
687870000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
768407000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
81400000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
71300000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
991401000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
983548000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
543376000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
517767000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
448025000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
465781000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71195000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58999000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
47047000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
48468000 usd
CY2024Q2 lcii Sales Rebates Accrual Current
SalesRebatesAccrualCurrent
23805000 usd
CY2023Q4 lcii Sales Rebates Accrual Current
SalesRebatesAccrualCurrent
19403000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48610000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47567000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
190657000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
174437000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
71578000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
54528000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
28228000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
40128000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
28439000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
31968000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
71367000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
62688000 usd
CY2024Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
24320000 usd
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20700000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
47047000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
41988000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5111000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6624000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
829746000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
847423000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
558000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
589000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
829188000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
846834000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
16162000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15670000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
31850000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
30914000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
964000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1307000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1951000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
2787000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1277000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1200000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2163000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2200000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
18403000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
18177000 usd
us-gaap Lease Cost
LeaseCost
35964000 usd
us-gaap Lease Cost
LeaseCost
35901000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28803000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28667000 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3341000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3341000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25462000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25326000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
4.20
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.10
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
200000000 shares
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
253490 shares
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
94.89
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24100000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Revenues
Revenues
1054544000 usd
CY2023Q2 us-gaap Revenues
Revenues
1014639000 usd
us-gaap Revenues
Revenues
2022573000 usd
us-gaap Revenues
Revenues
1987949000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
90604000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
55174000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
148215000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
75217000 usd
CY2023Q2 us-gaap Revenues
Revenues
1014639000 usd
us-gaap Revenues
Revenues
2022573000 usd
us-gaap Revenues
Revenues
1987949000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000763744-24-000109-index-headers.html Edgar Link pending
0000763744-24-000109-index.html Edgar Link pending
0000763744-24-000109.txt Edgar Link pending
0000763744-24-000109-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lcii-06302024xex311.htm Edgar Link pending
lcii-06302024xex312.htm Edgar Link pending
lcii-06302024xex321.htm Edgar Link pending
lcii-06302024xex322.htm Edgar Link pending
lcii-06x30x2024xex33xamend.htm Edgar Link pending
lcii-20240630.htm Edgar Link pending
lcii-20240630.xsd Edgar Link pending
lcii-20240630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
lcii-20240630_cal.xml Edgar Link unprocessable
lcii-20240630_htm.xml Edgar Link completed
lcii-20240630_lab.xml Edgar Link unprocessable
lcii-20240630_pre.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lcii-20240630_def.xml Edgar Link unprocessable